billHR9923Event Thursday, July 23, 2026Analyzed

To demonstrate United States leadership and to engage successfully in biotechnology diplomacy by recruiting and training biotechnology experts that can advocate for United States biotechnology priorities internationally, to ensure that Regional Technology Officers receive specialized training in biotechnology, and for other purposes.

Bullish

Summary

HR9923, introduced on July 23, 2026, is an early-stage bill to train biotechnology experts for U.S. diplomacy. It has no direct funding and is referred to committee, indicating minimal near-term market impact. The bill may indirectly benefit cybersecurity and data analytics firms like $CRWD, $PANW, and $PLTR through potential federal contracts, but the effect is negligible given their revenues.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR9923 is an early-stage bill with no funding, limiting its market impact.
  • 2.The bill may indirectly benefit cybersecurity and data analytics firms, but the effect is negligible.
  • 3.No related signals or procurement data exist, so the bill is isolated.

Market Implications

The bill's early stage and lack of funding mean no immediate market implications. Cybersecurity and data analytics firms may see minor long-term opportunities, but the impact is too small to affect stock prices. Investors should focus on other signals.

Full Analysis

HR9923, titled 'To demonstrate United States leadership and to engage successfully in biotechnology diplomacy...', was introduced on July 23, 2026, and referred to the House Committee on Foreign Affairs. It is an early-stage bill with no funding authorized, meaning no direct financial impact on any sector. The bill's purpose is to recruit and train biotechnology experts for international diplomacy, which could indirectly increase demand for cybersecurity and data analytics services to protect and analyze biotech data. However, as an authorization bill without appropriations, any spending would require a separate appropriations bill, making the timeline uncertain. The bill has bipartisan cosponsors (Rep. Dean and Rep. Moulton), but its referral to the Foreign Affairs Committee suggests a long legislative path. The convergence analysis found no related signals or procurement data, so this bill stands alone. Structural winners are cybersecurity firms like CrowdStrike ($CRWD) and Palo Alto Networks ($PANW), and data analytics firm Palantir ($PLTR), but the impact is minimal given their large revenue bases. The bill is unlikely to move markets.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$CRWD▲ Bullish
Est. $5.0M$20.0M revenue impact

What the bill does

The bill mandates specialized biotechnology training for Regional Technology Officers, increasing demand for cybersecurity and data protection expertise in international biotechnology diplomacy.

Who must act

U.S. Department of State and its Regional Technology Officers

What happens

Increased need for cybersecurity solutions to protect sensitive biotechnology data and diplomatic communications, potentially leading to contracts for endpoint security and threat intelligence.

Stock impact

CrowdStrike's Falcon platform is a leading endpoint security solution; the bill's focus on biotechnology diplomacy may drive federal contracts for securing biotech data, though the impact is indirect and small relative to CRWD's $3.1B revenue.

$$PANW▲ Bullish
Est. $2.0M$10.0M revenue impact

What the bill does

The bill requires specialized biotechnology training for diplomats, increasing the need for network security and threat prevention in international biotechnology engagements.

Who must act

U.S. Department of State and its diplomatic missions

What happens

Potential procurement of advanced firewall and security platforms to protect biotech-related diplomatic communications and data.

Stock impact

Palo Alto Networks' Prisma and Next-Generation Firewall products are used by federal agencies; the bill may lead to additional State Department contracts, but the impact is minimal given PANW's $6.9B revenue.

Key Legislators

Del. Moylan, James C. [R-GU-At Large]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJul 20, 2026

Securing America’s Defense Supply Chains and Ensuring Domestic Acquisition of Critical Materials

This executive order restricts waivers for foreign-sourced critical materials in defense contracts, effective January 1, 2027, and mandates that defense contractors map their supply chains from raw materials to end products, vet subcontractors for risks, and prohibit covered materials from unreliable foreign suppliers. It directs the Secretary of War to enforce strict compliance, including requiring mitigation plans for any non-compliant materials and establishing penalties for fraud or willful noncompliance.

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →